Summary
BioMimetic Therapeutics, Inc. (BioMimetic), subsidiary of Wright Medical Group, Inc., is a biotechnology company. It develops and commercializes products for the healing of musculoskeletal injuries and diseases which include orthopedics, sports medicine and spine applications. The Augment products are based upon the recombinant human platelet-derived growth factor (rhPDGF-BB) in combination with tissue specific matrices as its primary technology platform for promotion of tissue healing and regeneration. Further, the company’s range of products and product candidates combine recombinant protein therapeutics with tissue specific scaffolds that stimulate tissue healing and regeneration. BioMimetic is headquartered in Franklin, US.
BioMimetic Therapeutics, Inc. - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Global Therapy Industry
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
BioMimetic Therapeutics, Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013 4
BioMimetic Therapeutics, Inc., Medical Equipment Deals By Type, 2007 to YTD 2013 5
BioMimetic Therapeutics, Inc., Medical Equipment, Deals By Region, 2007 to YTD 2013 6
BioMimetic Therapeutics, Inc., Medical Equipment, Deals By Market, 2007 to YTD 2013 7
BioMimetic Therapeutics, Inc., Medical Equipment, Deals Summary, 2007 to YTD 2013 8
BioMimetic Therapeutics, Inc., Medical Equipment, Deal Details 9
BioMimetic Therapeutics Enters Into License Agreement With Luitpold Pharma 9
Equity Offering 10
BioMimetic Therapeutics Files Registration Statement For Public Offering Of Securities For US$150 Million 10
BioMimetic Therapeutics Completes Public Offering Of Common Stock For US$48 Million 11
BioMimetic Therapeutics Completes Rights Offering Of US$17 Million 13
BioMimetic Therapeutics Completes Private Placement Of Common Stock For US$8 Million 14
BioMimetic Therapeutics Completes Public Offering Of US$50.44 Million 16
Asset Transactions 18
BioMimetic Therapeutics Sells Remaining Dental Business To Luitpold Pharma 18
Acquisition 20
Wright Medical Completes Acquisition Of BioMimetic Therapeutics For Up To US$380 Million 20
BioMimetic Therapeutics, Inc. - Key Competitors 23
Key Employees 24
Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
Nov 05, 2012: BioMimetic Reports Q3 2012 Results 26
Aug 02, 2012: BioMimetic Reports Q2 2012 Results 27
May 09, 2012: BioMimetic Reports Q1 2012 Results 27
Mar 13, 2012: BioMimetic Reports Revenue Of $1.7m In 2011 28
Product News 29
Jan 03, 2013: BioMimetic Initiates Enrollment In Augment Chronic Tendinopathy Clinical Trial 29
Jun 21, 2012: BioMimetic Announce Presentation Of Clinical Results From Augment Injectable Bone Graft Clinical Trial At AOFAS Annual Meeting 30
Feb 06, 2012: BioMimetic Therapeutics Announces Results Of Its Augment Rotator Cuff Graft Clinical Trial At ORS And AAOS Meetings 31
Jan 03, 2012: BioMimetic Receives Augment Bone Graft PMA Response Letter From FDA 31
Jan 03, 2012: BioMimetic Receives CE Mark Approval To Market GEM 21S In EU 32
Product Approvals 33
Jan 03, 2012: BioMimetic Receives CE Mark Approval To Market GEM 21S In EU 33
Clinical Trials 34
Jan 03, 2013: BioMimetic Initiates Enrollment In Augment Chronic Tendinopathy Clinical Trial 34
Jun 21, 2012: BioMimetic Announce Presentation Of Clinical Results From Augment Injectable Bone Graft Clinical Trial At AOFAS Annual Meeting 34
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36
List of Tables
BioMimetic Therapeutics, Inc., Medical Equipment, Key Facts 1
BioMimetic Therapeutics, Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013 1
BioMimetic Therapeutics, Inc., Medical Equipment, Deals By Region, 2007 to YTD 2013 1
BioMimetic Therapeutics, Inc., Medical Equipment, Deals By Market, 2007 to YTD 2013 1
BioMimetic Therapeutics, Inc., Medical Equipment, Deals Summary, 2007 to YTD 2013 1
BioMimetic Therapeutics, Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013 4
BioMimetic Therapeutics, Inc., Medical Equipment Deals By Type, 2007 to YTD 2013 5
BioMimetic Therapeutics, Inc., Medical Equipment, Deals By Region, 2007 to YTD 2013 6
BioMimetic Therapeutics, Inc., Deals By Market, 2007 to YTD 2013 7
BioMimetic Therapeutics, Inc., Medical Equipment, Deals Summary, 2007 to YTD 2013 8
BioMimetic Therapeutics Enters Into License Agreement With Luitpold Pharma 9
BioMimetic Therapeutics Files Registration Statement For Public Offering Of Securities For US$150 Million 10
BioMimetic Therapeutics Completes Public Offering Of Common Stock For US$48 Million 11
BioMimetic Therapeutics Completes Rights Offering Of US$17 Million 13
BioMimetic Therapeutics Completes Private Placement Of Common Stock For US$8 Million 14
BioMimetic Therapeutics Completes Public Offering Of US$50.44 Million 16
BioMimetic Therapeutics Sells Remaining Dental Business To Luitpold Pharma 18
Wright Medical Completes Acquisition Of BioMimetic Therapeutics For Up To US$380 Million 20
BioMimetic Therapeutics, Inc., Key Competitors 23
BioMimetic Therapeutics, Inc., Key Employees 24
BioMimetic Therapeutics, Inc., Subsidiaries 25
List of Figures
BioMimetic Therapeutics, Inc., Medical Equipment, Deals by Type, 2007 to YTD 2013 1
BioMimetic Therapeutics, Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013 4
BioMimetic Therapeutics, Inc., Medical Equipment, Deals by Type, 2007 to YTD 2013 5
BioMimetic Therapeutics, Inc., Medical Equipment, Deals By Region, 2007 to YTD 2013 6
BioMimetic Therapeutics, Inc., Medical Equipment, Deals by Market, 2007 to YTD 2013 7
